Krystal Biotech, Inc.
KRYSDrugs in Pipeline
7
Phase 3 Programs
3
Upcoming Catalysts
4
Next Catalyst
Aug 3, 2026
4wMarket Overview
Stock performance and key metrics
4 upcoming, 0 past
How KRYS's past catalysts played out
Open Label Topical Beremagene Geperpavec (B-VEC)
Dystrophic Epidermolysis Bullosa
Topical beremagene geperpavec
Dystrophic Epidermolysis Bullosa
KB803
Dystrophic Epidermolysis Bullosa
KB801
Neurotrophic Keratitis
Opdualag
Cancer
KB707
Lung Cancer, Non-small Cell
KB304
Wrinkles in Decolletage
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Open Label Topical Beremagene Geperpavec (B-VEC) | Phase 3 | Dystrophic Epidermolysis Bullosa | - | - |
Topical beremagene geperpavec | Phase 3 | Dystrophic Epidermolysis Bullosa | - | - |
KB803 | Phase 3 | Dystrophic Epidermolysis Bullosa | - | - |
KB801 | Phase 2 | Neurotrophic Keratitis | - | - |
Opdualag | Phase 2 | Cancer | - | - |
KB707 | Phase 2 | Lung Cancer, Non-small Cell | - | - |
KB304 | Phase 2 | Wrinkles in Decolletage | - | - |
Dystrophic Epidermolysis Bullosa
3 drugs in this indication
Lung Cancer, Non-small Cell
1 drug in this indication
Neurotrophic Keratitis
1 drug in this indication
Wrinkles in Decolletage
1 drug in this indication
Cancer
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Krystal Biotech, Inc.'s drug pipeline?→
CatalystAlert tracks 7 drug candidates in Krystal Biotech, Inc.'s (KRYS) pipeline across Phase 3, Phase 2. Its lead program is Open Label Topical Beremagene Geperpavec (B-VEC) (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Krystal Biotech, Inc.'s next FDA catalyst?→
Krystal Biotech, Inc.'s (KRYS) next tracked catalyst is a Earnings expected August 3, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track KRYS biotech catalysts?→
Add KRYS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Krystal Biotech, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.